These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

718 related items for PubMed ID: 8691445

  • 1. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
    Müller CE, Geis U, Grahner B, Lanzner W, Eger K.
    J Med Chem; 1996 Jun 21; 39(13):2482-91. PubMed ID: 8691445
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synthesis and pharmacology of pyrido[2,3-d]pyrimidinediones bearing polar substituents as adenosine receptor antagonists.
    Bulicz J, Bertarelli DC, Baumert D, Fülle F, Müller CE, Heber D.
    Bioorg Med Chem; 2006 Apr 15; 14(8):2837-49. PubMed ID: 16377196
    [Abstract] [Full Text] [Related]

  • 4. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
    Baraldi PG, Cacciari B, Spalluto G, Pineda de las Infantas y Villatoro MJ, Zocchi C, Dionisotti S, Ongini E.
    J Med Chem; 1996 Mar 01; 39(5):1164-71. PubMed ID: 8676354
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Novel 3-aralkyl-7-(amino-substituted)-1,2,3-triazolo[4,5-d]pyrimidines with high affinity toward A1 adenosine receptors.
    Betti L, Biagi G, Giannaccini G, Giorgi I, Livi O, Lucacchini A, Manera C, Scartoni V.
    J Med Chem; 1998 Feb 26; 41(5):668-73. PubMed ID: 9513594
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
    Baraldi PG, Cacciari B, Spalluto G, Bergonzoni M, Dionisotti S, Ongini E, Varani K, Borea PA.
    J Med Chem; 1998 Jun 04; 41(12):2126-33. PubMed ID: 9622554
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.
    Müller CE, Geis U, Hipp J, Schobert U, Frobenius W, Pawłowski M, Suzuki F, Sandoval-Ramírez J.
    J Med Chem; 1997 Dec 19; 40(26):4396-405. PubMed ID: 9435909
    [Abstract] [Full Text] [Related]

  • 11. 7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.
    Müller CE, Hide I, Daly JW, Rothenhäusler K, Eger K.
    J Med Chem; 1990 Oct 19; 33(10):2822-8. PubMed ID: 2213835
    [Abstract] [Full Text] [Related]

  • 12. A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds.
    van Muijlwijk-Koezen JE, Timmerman H, Link R, van der Goot H, Ijzerman AP.
    J Med Chem; 1998 Oct 08; 41(21):3994-4000. PubMed ID: 9767637
    [Abstract] [Full Text] [Related]

  • 13. A novel class of adenosine A3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives.
    van Muijlwijk-Koezen JE, Timmerman H, Link R, van der Goot H, IJzerman AP.
    J Med Chem; 1998 Oct 08; 41(21):3987-93. PubMed ID: 9767636
    [Abstract] [Full Text] [Related]

  • 14. New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.
    Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP.
    J Med Chem; 2003 Jul 03; 46(14):2877-94. PubMed ID: 12825930
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and adenosine receptor binding studies of some novel triazolothienopyrimidines.
    Raghu Prasad M, Raghuram Rao A, Shanthan Rao P, Rajan KS, Meena S, Madhavi K.
    Eur J Med Chem; 2008 Mar 03; 43(3):614-20. PubMed ID: 17602796
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
    Pastorin G, Da Ros T, Spalluto G, Deflorian F, Moro S, Cacciari B, Baraldi PG, Gessi S, Varani K, Borea PA.
    J Med Chem; 2003 Sep 25; 46(20):4287-96. PubMed ID: 13678407
    [Abstract] [Full Text] [Related]

  • 18. 2-alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors.
    Vittori S, Camaioni E, Di Francesco E, Volpini R, Monopoli A, Dionisotti S, Ongini E, Cristalli G.
    J Med Chem; 1996 Oct 11; 39(21):4211-7. PubMed ID: 8863798
    [Abstract] [Full Text] [Related]

  • 19. The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognition.
    Cheong SL, Dolzhenko A, Kachler S, Paoletta S, Federico S, Cacciari B, Dolzhenko A, Klotz KN, Moro S, Spalluto G, Pastorin G.
    J Med Chem; 2010 Apr 22; 53(8):3361-75. PubMed ID: 20307065
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.